Feb 1, 2026
Most ViewedHow have recent Phase III anti‑amyloid readouts correlated amyloid plaque reduction with clinical benefit?
Recent Phase III readouts show a clear group‑level relationship: antibodies that produce large, sustained reductions in amyloid PET signal have tended to produce modest but statistically significant s...